DOPAMINE D-1 RECEPTOR, D-2 RECEPTOR, PROENKEPHALIN-A AND SUBSTANCE-P GENE-EXPRESSION IN THE CAUDATE-NUCLEUS OF CONTROL AND SCHIZOPHRENIC TISSUE - A QUANTITATIVE CELLULAR IN-SITU HYBRIDIZATION STUDY
Ka. Harrington et al., DOPAMINE D-1 RECEPTOR, D-2 RECEPTOR, PROENKEPHALIN-A AND SUBSTANCE-P GENE-EXPRESSION IN THE CAUDATE-NUCLEUS OF CONTROL AND SCHIZOPHRENIC TISSUE - A QUANTITATIVE CELLULAR IN-SITU HYBRIDIZATION STUDY, Molecular brain research, 33(2), 1995, pp. 333-342
The cellular expression of the mRNAs encoding the dopamine D-1 recepto
r, dopamine D-2 receptor and the neuropeptides enkephalin and substanc
e P was determined in fresh frozen sections of human post-mortem cauda
te nucleus from control and schizophrenic brains using the technique o
f radioactive in situ hybridisation coupled with computer-assisted ima
ge analysis. Measurements of silver grain densities and mean cross-sec
tional somatic areas revealed no significant differences in the expres
sion of any of these four gene transcripts. Further, cell count estima
tes revealed that each of these four mRNAs was expressed by approximat
ely 20% of caudate cells (neurones and glia) in both control and schiz
ophrenic tissue. These data demonstrate that the cellular expression o
f the dopamine D-1 and D-2 receptors and the neuropeptides enkephalin
and substance P mRNAs are stable post mortem and that the relative cel
lular abundance of these mRNAs is not altered in the caudate nucleus o
f schizophrenic brains when compared to controls. These findings draw
into focus the possible sites of action of clinically prescribed neuro
leptics and suggest that chronic neuroleptic treatment of patients dis
playing negative schizophrenic symptoms may 're-set' an underlying neu
rochemical imbalance within the caudate nucleus.